Home » Topics » Regulatory

Regulatory
RSS

Migraine prophylaxis with bisoprolol

Sep. 1, 1997

Famotidine for schizophrenia

Sep. 1, 1997

FDA clears new formulation of Imitrex

Sep. 1, 1997

First approval for irbesartan

Sep. 1, 1997

New indication approved for Asacol

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Living human tissue approved for marketing in Canada

Aug. 22, 1997

Supplemental NDA approved for Cipro

Aug. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.